FDA Approves New Drug To Combat Diabetes, Weight Gain

The FDA has approved a new diabetes drug that lowers blood sugar and also helps people lose weight.

 

fda

 

 

FDA: New Diabetes Drug

The once-a-week injection drug Ozempic (semaglutide) is approved for people with type 2 diabetes. It stimulates the body’s insulin production and reduces appetite.

 

The drug is from Danish company Novo Nordisk. A company-funded study of 1,200 type 2 diabetes patients found those who took Ozempic had average reductions in long-term blood sugar levels at least 2.5 times greater than those who took the daily diabetes pill Januvia.

 

Patients who took Ozempic also lost two to three times as much weight as those in the comparison group, the FDA reported.

 

FDA: What Is Type II Diabetes?

Diabetes is a problem with your body that causes blood glucose (sugar) levels to rise higher than normal. This is also called hyperglycemia. Type 2 diabetes is the most common form of diabetes.

If you have type 2 diabetes your body does not use insulin properly. This is called insulin resistance. At first, your pancreas makes extra insulin to make up for it. But, over time it isn’t able to keep up and can’t make enough insulin to keep your blood glucose at normal levels. Right now, Type 2 is treated with lifestyle changes, oral medications, and insulin.

Type 2 diabetes is the most common form of diabetes.

When glucose builds up in the blood instead of going into cells, it can cause two problems:

  • Right away, your cells may be starved for energy.
  • Over time, high blood glucose levels may hurt your eyes, kidneys, nerves, or heart.

Some people with type 2 can control their blood glucose with healthy eating and being active. But, your doctor may need to also prescribe oral medications or insulin to help you meet your target blood glucose levels. Type 2 usually gets worse over time.

Some groups have a higher risk for developing type 2 diabetes than others. Type 2 diabetes is more common in African Americans, Latinos, Native Americans, and Asian Americans/Pacific Islanders, as well as the aged population.

Leave a Comment





LET'S SCHEDULE A TOUR FOR YOU